Abdul Jabbar Shah Selected Research

Parasympatholytics (Antispasmodics)

11/2013	Chemical analysis and calcium channel blocking activity of the essential oil of Perovskia abrotanoides.
8/2011	Studies on the chemical composition and possible mechanisms underlying the antispasmodic and bronchodilatory activities of the essential oil of Artemisia maritima L.
9/2010	Calcium channel blocking activity of Mentha longifolia L. explains its medicinal use in diarrhoea and gut spasm.
1/2010	Antidiarrhoeal and spasmolytic activities of the methanolic crude extract of Alstonia scholaris L. are mediated through calcium channel blockade.
12/2006	Antispasmodic effect of Acorus calamus Linn. is mediated through calcium channel blockade.
11/2005	Presence of cholinergic and calcium channel blocking activities explains the traditional use of Hibiscus rosasinensis in constipation and diarrhoea.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Abdul Jabbar Shah Research Topics

Disease

5	Diarrhea 07/2019 - 02/2008
5	Colic (Abdominal Cramps) 11/2013 - 12/2006
4	Hypertension (High Blood Pressure) 08/2022 - 12/2005
3	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 11/2016 - 11/2005
3	Asthma (Bronchial Asthma) 03/2015 - 08/2011
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022 - 01/2012
2	Edema (Dropsy) 01/2022 - 03/2007
2	Constipation 02/2008 - 11/2005
2	Pain (Aches) 03/2007 - 12/2006
1	Ischemia 01/2022
1	Myocardial Infarction 01/2022
1	Necrosis 01/2022
1	Anxiety Disorders (Anxiety Disorder) 10/2020
1	Bronchial Spasm 07/2019
1	Corneal Neovascularization 01/2018
1	Inflammation (Inflammations) 01/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2015
1	Spasm (Spasms) 09/2010
1	Urolithiasis 08/2010
1	Hepatitis 06/2010
1	Epilepsy (Aura) 02/2008

Drug/Important Bio-Agent (IBA)

6	Parasympatholytics (Antispasmodics)IBA 11/2013 - 11/2005
5	Complex MixturesIBA 01/2022 - 11/2005
3	Plant ExtractsIBA 01/2022 - 12/2006
3	Calcium Channels (Calcium Channel)IBA 11/2013 - 11/2005
2	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 08/2012 - 08/2011
2	Anti-Arrhythmia AgentsIBA 01/2012 - 01/2011
2	Vasodilator Agents (Vasodilators)IBA 01/2012 - 01/2011
1	TriterpenesIBA 08/2022
1	Biological ProductsIBA 08/2022
1	PhytochemicalsIBA 01/2022
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022
1	CalciumIBA 01/2022
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2022
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2022
1	Troponin IIBA 01/2022
1	EndocannabinoidsIBA 10/2020
1	anandamide (arachidonylethanolamide)IBA 10/2020
1	Castor Oil (Oil, Castor)IBA 07/2019
1	Therapeutic UsesIBA 05/2019
1	Glycyrrhizic Acid (Glycyrrhizin)IBA 01/2018
1	Methanol (Carbinol)IBA 01/2018
1	PapaverineIBA 03/2015
1	Diltiazem (Cardizem)FDA LinkGeneric 03/2015
1	Volatile Oils (Essential Oils)IBA 01/2015
1	endothelium-dependent hyperpolarization factor (EDHF)IBA 01/2012
1	Bronchodilator Agents (Bronchodilators)IBA 08/2011
1	Atropine FDA LinkGeneric 01/2011
1	Petroleum (Crude Oil)IBA 09/2010
1	Ethylene Glycol (Monoethylene Glycol)IBA 08/2010
1	Drinking WaterIBA 08/2010
1	LipopolysaccharidesIBA 06/2010
1	GalactosamineIBA 06/2010
1	Hypnotics and Sedatives (Sedatives)IBA 02/2008
1	DiureticsIBA 02/2008
1	Diclofenac (SR 38)FDA LinkGeneric 03/2007
1	Indomethacin (Indometacin)FDA LinkGeneric 03/2007
1	n-hexaneIBA 12/2006
1	Cholinergic ReceptorsIBA 11/2005
1	Cholinergic Agents (Cholinergics)IBA 11/2005

Therapy/Procedure

4	Traditional Medicine (Folk Remedies) 07/2019 - 12/2005
1	Drug Therapy (Chemotherapy) 10/2020
1	Complementary Therapies (Alternative Medicine) 01/2015